Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cencora Inc
(NY:
COR
)
239.34
+0.93 (+0.39%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cencora Inc
< Previous
1
2
3
Next >
Here's How Much $100 Invested In Cencora 10 Years Ago Would Be Worth Today
March 13, 2024
Via
Benzinga
Here's How Much You Would Have Made Owning Cencora Stock In The Last 5 Years
February 28, 2024
Via
Benzinga
Critical Insights From Cencora Analyst Ratings: What You Need To Know
February 26, 2024
Via
Benzinga
US Federal Trade Commission Investigates Drug Shortages Amid Allegations Of Market Manipulation
February 14, 2024
FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scrutiny. Industry defends practices.
Via
Benzinga
Here's How Much $1000 Invested In Cencora 5 Years Ago Would Be Worth Today
February 09, 2024
Via
Benzinga
Why Walgreens Boots Alliance Stock Slumped 13.6% in January
February 08, 2024
The pharmacy giant ended an era.
Via
The Motley Fool
Wednesday Is Your Last Chance To Buy Cencora Before The Dividend Payout
February 05, 2024
Via
Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $12,000 Today
February 02, 2024
Via
Benzinga
Peering Into Cencora's Recent Short Interest
February 01, 2024
Via
Benzinga
Drug Wholesale Firm Cencora Starts 2024 With Strong Growth, Lifts Annual Forecast On Commercial COVID-19 Vaccine Distribution
January 31, 2024
Cencora reports Q1 2024 results with adjusted EPS at $3.28 and revenue of $72.3 billion. Explore the company's fiscal year 2024 guidance and growth projections.
Via
Benzinga
Exposures
COVID-19
Chart Of The Day: Cencora - Name Changed To Protect The Innocent?
January 17, 2024
Cencora, Inc. sources and distributes pharmaceutical products.
Via
Talk Markets
Is AI More Valuable In Advertising Than Healthcare? Jim Cramer Questions Wall Street's Preference
January 10, 2024
Cramer shared his insights during his attendance at JPMorgan's healthcare conference,
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
If You Invested $100 In This Stock 5 Years Ago, You Would Have $300 Today
December 18, 2023
Via
Benzinga
Here's How Much You Would Have Made Owning Cencora Stock In The Last 15 Years
December 06, 2023
Via
Benzinga
(COR) - Analyzing Cencora's Short Interest
December 05, 2023
Via
Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,300 Today
November 21, 2023
Via
Benzinga
How Is The Market Feeling About Cencora?
November 17, 2023
Via
Benzinga
Here's How Much $1000 Invested In Cencora 5 Years Ago Would Be Worth Today
October 31, 2023
Via
Benzinga
Earnings Scheduled For January 31, 2024
January 31, 2024
Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion.
Via
Benzinga
How Is The Market Feeling About Cencora?
January 11, 2024
Via
Benzinga
Here's How Much You Would Have Made Owning Cencora Stock In The Last 20 Years
January 05, 2024
Via
Benzinga
This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks
December 04, 2023
New growth drivers are helping to propel these reliable and steady businesses.
Via
The Motley Fool
Jim Cramer: Buy Shares Of This Personal Computer Giant, Wait For 'A Little Bit Of Pullback'
November 29, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he would not buy CRISPR Therapeutics AG (NASDAQ: CRSP) stock "all the way up here.
Via
Benzinga
3 Biotech Stocks You’ll Regret Not Buying Soon: November 2023
November 14, 2023
The global biotechnology market could nearly triple by 2030. Investors should consider buying these biotech stocks before they explode.
Via
InvestorPlace
Stock Market Rally Back In Force As Treasury Yields Plunge; Arista, Palantir Among Winners: Weekly Review
November 03, 2023
Bulls are back in control as the major indexes confirmed the uptrend this week.
Via
Investor's Business Daily
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $12,000 Today
October 18, 2023
Via
Benzinga
Peering Into Cencora's Recent Short Interest
October 17, 2023
Via
Benzinga
Obesity And Diabetes Drugs Demand Help Distributor Cencora Propel Revenue In Q3
November 02, 2023
Cencora Inc's (NYSE: COR), formerly AmerisourceBergen Corporation,
Via
Benzinga
Earnings Due For Stealth GLP-1 Weight-Loss Drug Play McKesson, Rivals
November 01, 2023
McKesson earnings are on tap, with Cencora and Cardinal Health due soon.
Via
Investor's Business Daily
Peering Into Cencora's Recent Short Interest
September 29, 2023
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.